INCIDENCIA Y PREVALENCIA DE LA INFECCION POR HIV DE RECIENTE DIAGNOSTICO DURANTE EL PERIODO DE ATENCION PRENATAL. PUESTA AL DIA
|
(especial para SIIC © Derechos reservados) |
|
La seroconversión, aunque infrecuente, es posible durante el embarazo. La repetición de la serología después de la primera visita de control prenatal permite adoptar las medidas terapéuticas y profilácticas necesarias. |
participaron en la investigación
Nancy L. Eriksen, MD* Andrew W. Helfgott, MD**
Associate Professor of Maternal-Fetal Medicine, Medical School of the University of Texas Houston Health Science Center*
Clinical Associate Professor and Director of the Regional Perinatal Center, Department of Obstetrics and Gynecology/Pensacola of University of Florida, Florida, EE.UU.**
|
Resumen
El estudio es una actualización de un trabajo previamente publicado sobre la transmisión del virus de la inmunodeficiencia humana (HIV) durante el período de atención prenatal. El trabajo anterior en 97 mujeres (1996-1997) reveló la falta de transmisión del HIV durante el período en el cual las mujeres recibieron cuidados prenatales. El seguimiento (1997-2002) mostró que 3 de las 180 mujeres estudiadas seroconvirtieron mientras recibían atención prenatal. El fenómeno obliga a reconsiderar una reevaluación serológica en mujeres con un resultado serológico negativo en la primera visita prenatal.
Palabras clave
Virus de la inmunodeficiencia humana, gestación, transmisión, seroconversión
Clasificación en siicsalud
Artículos originales> Expertos del Mundo>
página www.siicsalud.com/des/des029/02805001.htm
Especialidades
Principal: Obstetricia y Ginecología
Relacionadas: Infectología, Epidemiología, Diagnóstico por Laboratorio
Artículo completo
(castellano)
Extensión:
+/- 7.16 páginas impresas en papel A4
Exclusivo para suscriptores/ assinantes |
INCIDENCE AND PREVALENCE OF NEWLY DISCOVERED HUMAN IMMUNODEFICIENCY VIRUS INFECTION DURING THE PRENATAL CARE PERIOD - AN UPDATE
Abstract
This study is an update of previously published research on HIV transmission during the prenatal care period. The previous study of 97 women showed that no HIV transmission occurred during the time in which the women were receiving prenatal care. The follow up study showed that 3 of 180 women seroconverted while they were receiving prenatal care. The question of retesting pregnant women who tested negative at the first prenatal visit is discussed.
Key words
Human immunodeficiency virus, pregnancy, transmission, seroconversion
Full text
(english)
para suscriptores/ assinantes
|
Bibliografía del artículo
- Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and adolescents. Found at www.hivatis.org
- 2001 USPHS/IDSA Guidelines for the prevention of opportunistic infection in persons infected with the human immunodeficiency virus. Found at http://hivatis.org/guidleines.
- Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-88.
- Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med. 1994;331:1173-80.
- Landesman SH, Kalish LA, Burns DN, C et al. Obstetrical factors and the transmission of Human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334:1617-23.
- Perinatal HIV Guidelines Working Group. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Found at WWW.HIVATIS.org
- Grimes RM, Srivastava G, Helfgott AW, Eriksen NL. A study to determine the incidence and prevalence of newly discovered Human immunodeficiency virus infection during the prenatal care period. Infect Dis Obstet Gynecol. 2000;8:172-5.
- Lallemant M, Jourdain G, Le Cour S et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med 2000;343:982-91.
- Dabis F, Msellati P, Meda et al. 6-month efficacy, tolerance and acceptability of a a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in a Cote d'Ivoire and Burikino Faso: a double blind placebo-controlled multi-centre trial. Lancet. 1999;353:786-92.
- Guay LA, Musoke P, fleming T et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for preventionof mother-to-child transmission of HIV-1 in Kampala Uganda. Lancet. 1999;354:795-802.
- Wade NA, Birkhead GS, Warren BL et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339:1409-14.
- Phillips KA, Lowe RA, Kahn JG et al. The cost effectiveness of HIV testing physicians and dentists in the United States. JAMA 1994;271:851-8.
|
|
|
©
Está
expresamente prohibida la redistribución y la redifusión de todo o parte de los
contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin
previo y expreso consentimiento de SIIC. |
|
|
